Real-Life Effectiveness and Tolerability of Brivaracetam in Focal to Bilateral and Primary Generalized Tonic-Clonic Seizures

<div>Response (a) and tonic-clonic seizure freedom (b) rates in patients with focal or generalized epilepsy. Similar response rates were observed in the two groups at 3-, 6-, and 12-month follow-ups, whereas tonic-clonic seizure freedom rates were higher in patients with focal epilepsy. Tonic-clonic seizure freedom rates above 55% were seen in both groups throughout follow-up. TCS: tonic-clonic seizures.</div>

Acta Neurologica Scandinavica

fig2

Figure 2

Figure 2: Real-Life Effectiveness and Tolerability of Brivaracetam in Focal to Bilateral and Primary Generalized Tonic-Clonic Seizures 